Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Specialty Medicine

Bayer symbol

Bayer and Regeneron to develop second wet AMD therapy

Will collaborate on drug to be used in combination with Eylea

China flag thumb

Sinopharm executives face corruption probe in China

Two employees said to be detained for misappropriating company funds

Bayer symbol

Bayer establishes research centre in Beijing

Pharma company will collaborate on cardiology, oncology, haematology and gynaecology projects

China flag thumb

China says hepatitis B vaccines not cause of infant deaths

But suspension on production remains in place

A drug bottle with a 'like' option on the label

05 Social Media: A Health Hazard?

The case to embrace going social

Havas Lynx

Bayer symbol

Bayer agrees $2.9bn deal for Algeta to get Xofigo control

Raises initial offer to buy Norweigan pharma company

- PMLiVE

Digital blooms: multichannel marketing in China

The evolution of marketing and its increasing use of new channels is as relevant to China as it is to mature pharma markets

EU flag

EU discusses action on stroke prevention

Stakeholders meet at European Parliament

Janssen’s UK head moves to China

Cesar Rodriguez appointed managing director of Xian Janssen

Bayer symbol

Bayer offers $2.4bn to buy Xofigo partner Algeta

Norwegian firm says negotiations still at 'an early stage'

- PMLiVE

Nexavar cleared for thyroid cancer by FDA

Bayer and Onyx win expansion of oncology drug’s use in US

Bayer symbol

EU approval for Bayer’s prostate cancer drug

Xofigo wins marketing authorisation from European Commission

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links